|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||
| Net (loss) income | ||||
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | ||||
| Depreciation | ||||
| Amortization | ||||
| Foreign currency losses (gain) on foreign denominated debt | ||||
| Equity-based compensation | ||||
| Non-cash fair value adjustment for common stock warrants | ||||
| Deferred income taxes – net | ||||
| Uncertain tax positions | ||||
| Impairment of equity method investment | ||||
| Debt and refinance issuance transaction costs | ||||
| Non-cash fair value adjustment for swaps and foreign currency exchange contracts | ||||
| Amortization of debt issuance costs | ||||
| Non cash operating lease costs | ||||
| Impairment of right of use assets | ||||
| Loss on extinguishment of debt | ||||
| Transaction costs allocated to common stock warrants | ||||
| Non-cash fair value adjustment of contingent consideration | ||||
| Other | ||||
| Changes in assets and liabilities: | ||||
| Accounts receivable | ||||
| Accounts payable | ||||
| Accrued expenses | ||||
| Insurance recovery receivable | ||||
| Litigation reserves | ||||
| Lease liabilities, non-current | ||||
| Income taxes receivable/payable | ||||
| Interest payable | ||||
| Deferred revenue | ||||
| Other | ||||
| Net cash provided by operating activities | ||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||||
| Acquisition of property and equipment | ||||
| Purchase of a minority investment | ||||
| Acquisition of a business, net of cash acquired | ||||
| Other investing activities | ||||
| Net cash used in investing activities | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||
| Payment of debt | ||||
| Payment of contingent consideration | ||||
| Payment of Redeemable Preferred Stock | ||||
| Cash contributions from business combination | ||||
| Proceeds from issuance of debt | ||||
| Debt issuance and refinance costs | ||||
| Proceeds from common stock issuance | ||||
| Cash paid for settlement of employee taxes related to exercise of equity-based awards | ||||
| Cash paid for equity issuance costs | ||||
| Proceeds from option and warrant exercises | ||||
| Redemption of warrants for cash | ||||
| Net cash provided by (used in) financing activities | ||||
| Effects of exchange rates fluctuations | ||||
| NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | ||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH - Beginning of period | ||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH - End of period | ||||
| SUPPLEMENTAL DISCLOSURES: | ||||
| Interest paid | ||||
| Income taxes paid, including foreign taxes withheld |
Loading...